Lonza to Invest $45 Million to Expand Vitamin B3 Capacity in China
05:42 AM | May 11, 2010 | Deepti Ramesh
Lonza says it will invest about SF50 million ($45 million) to build a new nicotinates (vitamin B3) manufacturing plant at the company’s existing production site at Nansha, China. The new facility will...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.